Interim results from non-interventional study to evaluate cutaneous and circulating biomarkers for a novel IRAK4-targeted therapeutic in patients with hidradenitis suppurativa

October 9, 2020

5th Annual Symposium on Hidradenitis Suppurativa Advances (SHSA)

image
Area of Focus
Immunology
Programs
IRAK4 (KT-474)
Indications
Hidradenitis Suppurativa (HS)
Development Stage
Clinical Data
Share
LinkedInXFacebookEmailCopy Link